Diversified Trust Co Has $684,000 Holdings in MetLife, Inc. $MET

Diversified Trust Co lessened its holdings in MetLife, Inc. (NYSE:MET) by 73.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,301 shares of the financial services provider’s stock after selling 23,301 shares during the quarter. Diversified Trust Co’s holdings in MetLife were worth $684,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in MET. Norges Bank bought a new stake in MetLife during the 2nd quarter worth about $756,104,000. Pzena Investment Management LLC increased its position in shares of MetLife by 6.8% in the second quarter. Pzena Investment Management LLC now owns 9,144,635 shares of the financial services provider’s stock valued at $735,412,000 after acquiring an additional 585,671 shares during the last quarter. Invesco Ltd. raised its holdings in MetLife by 2.5% during the second quarter. Invesco Ltd. now owns 6,624,582 shares of the financial services provider’s stock worth $532,749,000 after acquiring an additional 162,041 shares in the last quarter. Amundi boosted its position in MetLife by 40.2% during the second quarter. Amundi now owns 4,507,362 shares of the financial services provider’s stock valued at $361,265,000 after purchasing an additional 1,292,107 shares during the last quarter. Finally, Nordea Investment Management AB grew its stake in MetLife by 1.9% in the second quarter. Nordea Investment Management AB now owns 4,426,101 shares of the financial services provider’s stock valued at $355,239,000 after purchasing an additional 80,633 shares in the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Price Performance

NYSE:MET opened at $80.31 on Friday. The company has a market cap of $52.91 billion, a P/E ratio of 15.12, a P/E/G ratio of 0.66 and a beta of 0.76. The firm’s fifty day moving average price is $78.66 and its two-hundred day moving average price is $78.98. MetLife, Inc. has a one year low of $65.21 and a one year high of $88.09. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.18 and a quick ratio of 0.18.

MetLife (NYSE:MET) last announced its earnings results on Wednesday, November 5th. The financial services provider reported $2.37 EPS for the quarter, topping the consensus estimate of $2.30 by $0.07. The business had revenue of $12.46 billion during the quarter, compared to the consensus estimate of $18.64 billion. MetLife had a net margin of 5.30% and a return on equity of 21.00%. MetLife’s revenue was down 5.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.95 EPS. Equities analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 4th were given a $0.5675 dividend. The ex-dividend date of this dividend was Tuesday, November 4th. This represents a $2.27 annualized dividend and a dividend yield of 2.8%. MetLife’s dividend payout ratio is presently 42.75%.

Analyst Upgrades and Downgrades

MET has been the topic of a number of analyst reports. UBS Group dropped their price objective on MetLife from $96.00 to $95.00 and set a “buy” rating on the stock in a research note on Thursday, November 6th. Wolfe Research raised shares of MetLife to a “strong-buy” rating in a research report on Tuesday, September 16th. Wells Fargo & Company increased their price target on shares of MetLife from $92.00 to $94.00 and gave the company an “overweight” rating in a research note on Tuesday, December 23rd. Weiss Ratings restated a “buy (b-)” rating on shares of MetLife in a research note on Monday. Finally, Mizuho assumed coverage on shares of MetLife in a research note on Monday, December 15th. They issued an “outperform” rating and a $101.00 target price for the company. Two equities research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $95.73.

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.